Invariant NKT Cell-Mediated Modulation of ILC1s as a Tool for Mucosal Immune Intervention
Non-NK group 1 innate lymphoid cells (ILC1s), mainly investigated in the mucosal areas of the intestine, are well-known to contribute to anti-parasitic and anti-bacterial immune responses. Recently, our group revealed that lung ILC1s become activated during murine influenza infection, thereby contri...
Main Authors: | Stephanie Trittel, Neha Vashist, Thomas Ebensen, Benedict J. Chambers, Carlos A. Guzmán, Peggy Riese |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01849/full |
Similar Items
-
Editorial: NKT Cells in Cancer Immunotherapy
by: Tonya J. Webb, et al.
Published: (2020-06-01) -
Erratum: Editorial: NKT Cells in Cancer Immunotherapy
by: Frontiers Production Office
Published: (2020-08-01) -
α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
by: Yingting Zhang, et al.
Published: (2019-06-01) -
CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
by: Lisa A. King, et al.
Published: (2018-07-01) -
Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
by: Lisa A. King, et al.
Published: (2018-11-01)